>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
身体成分变化与乳腺癌诊疗相关研究进展
作者:史雨鑫1  靳激扬2 
单位:1. 东南大学 医学院, 江苏 南京 210009;
2. 东南大学附属中大医院 放射科, 江苏 南京 210009
关键词:乳腺癌 身体成分 机制 预后 综述 
分类号:R737.9
出版年·卷·期(页码):2024·43·第三期(478-482)
摘要:

身体成分是指人体内各组织成分,其变化与生活方式、激素水平、慢性炎症以及外源性药物有关,在肿瘤患者中尤为明显,被认为与肿瘤的发生发展密切相关,目前已经成为多种实体瘤的研究热点。乳腺癌是严重威胁女性健康的恶性肿瘤之一,本文作者就身体成分变化的病理生理学机制、测量方法及其在乳腺癌诊疗中的应用现状作一综述。

参考文献:

[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] 刘雪薇,王媛,韦丹梅,等.1990—2019年中国女性乳腺癌发病及死亡趋势的年龄-时期-队列模型分析[J].中国全科医学,2023,26(1):34-41.
[3] PAPADOPOULOU S K.Sarcopenia: a contemporary health problem among older adult populations[J].Nutrients,2020,12(5):1293.
[4] POOLE L P,MACLEOD K F.Mitophagy in tumorigenesis and metastasis[J].Cell Mol Life Sci,2021,78(8):3817-3851.
[5] MARLATT K L,REDMAN L M,BEYL R A,et al.Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study[J].Am J Obstet Gynecol,2020,222(4):365.e1-365.e18.
[6] IWASE T,WANG X,SHRIMANKER T V,et al.Body composition and breast cancer risk and treatment: mechanisms and impact[J].Breast Cancer Res Treat,2021,186(2): 273-283.
[7] PATAKY M W,YOUNG W F,NAIR K S.Hormonal and metabolic changes of aging and the influence of lifestyle modifications[J].Mayo Clin Proc,2021,96(3):788-814.
[8] TAYLOR J A,GREENHAFF P L,BARTLETT D B,et al.Multisystem physiological perspective of human frailty and its modulation by physical activity[J].Physiol Rev,2023, 103(2):1137-1191.
[9] PARARASA C,BAILEY C J,GRIFFITHS H R.Ageing, adipose tissue, fatty acids and inflammation[J].Biogerontology,2015,16(2):235-248.
[10] DIXON J K,MORITZ D A,BAKER F L.Breast cancer and weight gain: an unexpected finding[J].Oncol Nurs Forum,1978,5(3):5-7.
[11] FANG Q,GAN L,CHEN Y Y,et al.Percent body fat change in Chinese women after adjuvant chemotherapy for breast cancer[J].Med Sci Monit,2018,24:5988-5995.
[12] TARPEY M D,AMORESE A J,BALESTRIERI N P,et al.Doxorubicin causes lesions in the electron transport system of skeletal muscle mitochondria that are associated with a loss of contractile function[J].J Biol Chem,2019,294(51):19709-19722.
[13] CENICCOLA G D,CASTRO M G,PIOVACARI S M F,et al.Current technologies in body composition assessment: advantages and disadvantages[J].Nutrition,2019,62: 25-31.
[14] ANYENE I,CAAN B,WILLIAMS G R,et al.Body composition from single versus multi-slice abdominal computed tomography: Concordance and associations with colorectal cancer survival[J].J Cachexia Sarcopenia Muscle,2022,13(6): 2974-2984.
[15] TAGLIAFICO A S,BIGNOTTI B,TORRI L,et al. Sarcopenia: how to measure, when and why[J].Radiol Med,2022,127(3):228-237.
[16] ROSSI F,VALDORA F,BARABINO E,et al.Muscle mass estimation on breast magnetic resonance imaging in breast cancer patients: comparison between psoas muscle area on computer tomography and pectoralis muscle area on MRI[J].Eur Radiol,2019,29(2): 494-500.
[17] SHACHAR S S,DEAL A M,WEINBERG M,et al.Body composition as a predictor of toxicity in patients receiving anthracycline and taxane-based chemotherapy for early-stage breast cancer[J].Clin Cancer Res,2017,23(14):3537-3543.
[18] SHACHAR S S,DEAL A M,WEINBERG M,et al.Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy[J].Clin Cancer Res,2017,23(3):658-665.
[19] VAN DEN BERG M M G A,KOK D E,POSTHUMA L,et al.Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy[J].Breast Cancer Res Treat,2019,173(2): 475-481.
[20] ALEIXO G F P,YU H,CHEN Y T,et al.Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer[J].Breast Cancer Res Treat,2021,186(2):487-495.
[21] 李丽,张亚男,尤承忠.乳腺癌新辅助化疗的研究进展[J].东南大学学报(医学版), 2013,32(6):766-771.
[22] IWASE T,SANGAI T,NAGASHIMA T,et al.Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients[J].Cancer Med,2016,5(1): 41-48.
[23] TRESTINI I,CALDART A,CINTONI M,et al.Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer[J].Nutrition,2023, 105:111858.
[24] OMARINI C,PALUMBO P,PECCHI A,et al.Predictive role of body composition parameters in operable breast cancer patients treated with neoadjuvant chemotherapy[J].Cancer Manag Res,2019,11:9563-9569.
[25] DEL FABBRO E,PARSONS H,WARNEKE C L,et al.The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer[J].Oncologist,2012,17(10):1240-1245.
[26] MORIKAWA H,OBA T,KIYOSAWA N,et al.Significance of skeletal muscle index-to-body mass index ratio as a predictor of post-surgical bleeding after mastectomy in patients with breast cancer[J].Breast Cancer,2023,30(6):933-942.
[27] DINIS J,JUNN A,SHAH R,et al.Abdominal subcutaneous fat thickness as a substitute for BMI in predicting complications in abdominally-based autologous breast reconstruction[J].Microsurgery,2021,41(4):341-347.
[28] YABE S,NAKAGAWA T,ODA G,et al.Association between skin flap necrosis and sarcopenia in patients who underwent total mastectomy[J].Asian J Surg,2021,44(2): 465-470.
[29] NAKAMURA H,MAKIGUCHI T,YAMAGUCHI T,et al.Impact of skeletal muscle mass on complications following expander breast reconstruction[J].J Plast Reconstr Aesthet Surg,2020,73(7):1285-1291.
[30] ALEIXO G F P,VALENTE S A,WEI W,et al.Association of body composition and surgical outcomes in patients with early-stage breast cancer[J].Breast Cancer Res Treat, 2023,202(2):305-311.
[31] AMITANI M,OBA T,KIYOSAWA N,et al.Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer[J].BMC Cancer, 2022,22(1):327.
[32] DELUCHE E,LEOBON S,DESPORT J C,et al.Impact of body composition on outcome in patients with early breast cancer[J].Support Care Cancer,2018,26(3):861-868.
[33] CAAN B J,CESPEDES FELICIANO E M,PRADO C M,et al.Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer[J].JAMA Oncol,2018,4(6):798-804.
[34] HUANG W J,ZHANG M L,WANG W,et al.Preoperative pectoralis muscle index predicts distant metastasis-free survival in breast cancer patients[J].Front Oncol,2022, 12:854137.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 453906 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058364